肺癌手术市场规模、份额、成长分析，按设备类型、最终用户、地区划分 - 产业预测 2024-2031

2022年全球肺癌手术市场规模为56亿美元，从2023年的59亿美元成长到2031年的81亿美元，在预测期内（2024-2031年）复合年增长率为4.1%。

全球市场细分 该市场是医疗保健行业中一个充满活力的部分，受与肺癌相关的高盛行率和死亡率的推动。外科技术和技术的最新进展，特别是电视辅助胸腔手术 (VATS) 和机器人辅助手术等微创手术，改善了患者的治疗效果，包括减轻疼痛和缩短恢復时间。主要市场驱动因素包括肺癌发生率上升、早期检测意识增强以及人口老化。儘管取得了这些进展，但挑战仍然存在，例如治疗成本上升以及发展中地区的治疗机会差异。医疗设备製造商、医院和研究机构之间正在进行的研究工作和合作旨在克服这些障碍，并提高全球肺癌手术的可用性和有效性。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 生态系绘图
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 案例研究
• 技术评估
• 监管环境
• 疾病流行病学
• 专利分析

肺癌手术市场规模：依设备类型及复合年增长率（2024-2031）

• 市场概况
• 手术器械
  • 粉体手术器械
  • 手用仪器
  • 订书机
  • 钳子
  • 牵开器
  • 肋骨剪刀
  • 刀具
  • 夹钳
  • 剪刀
  • 套管针
  • 电梯
  • 其他的
• 监控及视觉化系统
  • 相机和视频支持
  • 具有光学视野的内视镜套管针
• 内视镜手术设备

肺癌手术市场规模：按类型和复合年增长率（2024-2031）

• 市场概况
• 开胸手术
  • 切除术
  • 袖状切除术
  • 部分切除术
  • 肺切除术
• 微创手术

肺癌手术市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 医院
• 门诊手术中心

肺癌手术市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
• 产品系列分析
• 按细分市场分類的份额分析
• 收益与前一年同期比较（2021-2023）

主要企业简介

• Ethicon Llc.（Johnson & Johnson Group）
• Medtronic Plc.
• Olympus Corporation
• Intuitive Surgical Inc.
• Siemens Healthineers
• Teleflex Incorporated
• Accuray Incorporated
• Angiodynamics Inc.
• Key Surgical Llc.
• KLS Martin Group
• Ackermann Instrumente Gmbh
• Karl Storz Gmbh
• Scanlan International, Inc.
• Trokamed Gmbh
• Surgical Holdings
• Fusionkraft Surgical Instruments
• Richard Wolf Gmbh
• Sontec Instruments Inc.
• Wexler Surgical Inc.
• Phoenix Surgical Instruments Ltd.（Steris Ims）

结论和建议

Global Lung Cancer Surgery Market size was valued at USD 5.6 billion in 2022 and is poised to grow from USD 5.9 billion in 2023 to USD 8.1 billion by 2031, growing at a CAGR of 4.1% during the forecast period (2024-2031).

The global Lung Cancer Surgery market is a dynamic segment of the healthcare industry, driven by the high prevalence and mortality associated with lung cancer. Recent advancements in surgical techniques and technologies, particularly minimally invasive procedures like video-assisted thoracic surgery (VATS) and robotic-assisted surgery, have led to improved patient outcomes, including reduced pain and shorter recovery times. Key market growth drivers include the rising incidence of lung cancer, heightened awareness for early detection, and an aging population. Despite these advancements, challenges such as high treatment costs and access disparities in developing regions persist. Ongoing research efforts and collaborations among medical device manufacturers, hospitals, and research institutions aim to overcome these obstacles, enhancing the availability and effectiveness of lung cancer surgeries globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lung Cancer Surgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lung Cancer Surgery Market Segmental Analysis

Global Lung Cancer Surgery Market is segmented by Device Type, Type, End-User and Region. Based on Device Type, the market is segmented into Surgical instruments, Monitoring & Visualizing Systems, Endosurgical Equipment. Based on Type, the market is segmented into Thoracotomy, Minimally Invasive Surgeries. Based on End-User, the market is segmented into Hospitals, Ambulatory Surgery Centres. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lung Cancer Surgery Market

The global lung cancer surgery market is significantly driven by the rising prevalence of lung cancer, recognized as the leading cause of cancer-related deaths among both men and women worldwide. This alarming trend is largely attributed to the tobacco epidemic, particularly in developing countries, where the rates of lung cancer incidence and mortality are sharply increasing. The profound impact of lung cancer extends beyond physical health, profoundly affecting patients and their families, and it is increasingly regarded as a critical global health challenge. Lung cancer itself is characterized by the uncontrolled growth of lung cell tissues, necessitating effective surgical interventions for treatment.

Restraints in the Global Lung Cancer Surgery Market

The global lung cancer surgery market faces several restraints that may hinder its growth. One significant factor is the high cost associated with the surgical procedures, which can deter patients and healthcare providers from pursuing necessary treatments. Additionally, technical limitations present in certain countries further restrict the availability of advanced surgical options. Prolonged lead times required for obtaining international qualifications can complicate market entry and expansion efforts. Furthermore, the fierce competition within the medical technology sector adds another layer of challenge, potentially stifling innovation and limiting the overall progress of the lung cancer surgery market.

Market Trends of the Global Lung Cancer Surgery Market

The Global Lung Cancer Surgery market is experiencing a significant trend towards increased research and development, aimed at enhancing treatment modalities and surgical techniques. Ongoing clinical trials are pivotal in evaluating the effectiveness and safety of innovative approaches, such as targeted therapies, immunotherapies, and minimally invasive procedures. This trend is driven by the rising incidence of lung cancer globally, leading to a surge in demand for advanced surgical interventions. As pharmaceutical and medical device companies invest heavily in R&D, the market anticipates a wave of breakthroughs, ultimately improving patient outcomes and transforming standard practices in lung cancer treatment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Disease Epidemiology
• Patent Analysis

Global Lung Cancer Surgery Market Size by Device Type & CAGR (2024-2031)

• Market Overview
• Surgical instruments
  • Powdered Surgical Instruments
  • Hand Instruments
  • Staplers
  • Forceps
  • Retractors
  • Rib Shears
  • Cutters
  • Clamps
  • Scissors
  • Trocars
  • Elevators
  • Others
• Monitoring & Visualizing Systems
  • Cameras and Video Support
  • Endoscopic Trocars with Optical Views
• Endosurgical Equipment

Global Lung Cancer Surgery Market Size by Type & CAGR (2024-2031)

• Market Overview
• Thoracotomy
  • Lobectomy
  • Sleeve Resection
  • Segmentectomy
  • Pneumonectomy
• Minimally Invasive Surgeries

Global Lung Cancer Surgery Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Ambulatory Surgery Centres

Global Lung Cancer Surgery Market Size & CAGR (2024-2031)

• North America (Device Type, Type, End-User)
  • US
  • Canada
• Europe (Device Type, Type, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Device Type, Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Device Type, Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Ethicon Llc. (Johnson & Johnson Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angiodynamics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Key Surgical Llc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLS Martin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ackermann Instrumente Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karl Storz Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scanlan International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trokamed Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgical Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fusionkraft Surgical Instruments
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sontec Instruments Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wexler Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phoenix Surgical Instruments Ltd. (Steris Ims)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation